| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| CLN-619 | CLN-619 | Phase 1 Clinical | PDI Therapeutics Inc | Solid tumours | Details |
| FT-536 | FT-536 | Phase 1 Clinical | Fate Therapeutics Inc | Ovarian Neoplasms; Solid tumours; Abdominal Neoplasms; Genital Neoplasms, Female; Fallopian Tube Neoplasms | Details |
| DM-919 | DM-919; DM919 | Phase 1 Clinical | D2M Biotherapeutics Inc | Solid tumours; Neoplasms | Details |